GMCSF is known to improve lung immunity by accelerating bacterial clearance and neutrophil recruitment [46, 49] while IL-6 contributes to lung defense by orchestrating the pro- and anti-inflammatory cytokine network [50], thus emphasizing the relevance of this study to the pathogenesis of pneumococcal pneumonia. This evidence concerns the gene IL6 and pneumococcal pneumonia.